Arf (ADP-ribosylation factor) proteins form a special class of small GTP-binding proteins in that their activation by GDP/GTP exchange is coupled to their recruitment to membranes using a built-in structural mechanism. These coupled processes are stimulated by GEFs (guanine nucleotide-exchange factors) that carry a catalytic Sec7 domain, whose basic mechanism has been uncovered by biochemical and structural studies. Crystal structures of intermediates of the GDP/GTP exchange reaction, from which GDP has not dissociated, notably allowed a movie of the exchange reaction to be reconstituted. They showed that Sec7 domains secure Arf-GDP to membranes before they proceed to nucleotide dissociation, and thus are active participants to the coupling of membrane-recruitment to nucleotide exchange. The drug BFA (Brefeldin A) was used to trap the complex that initiates the exchange reaction, providing a structural basis for its inhibition of Arf and its action on the membrane-recruitment of isolated Sec7 domains. Based on the dissection of this basic mechanism, the survey of reported BFA effects in cells on large multidomain ArfGEFs of the BIG1/2 and GBF1 families shows that the levels and compartmental distribution of BFA-induced recruitment of ArfGEFs to membranes cannot be explained from isolated Sec7 domains acting as independent domains. This leads to the hypothesis that Sec7 activity is inhibited in these ArfGEFs by an intramolecular interaction, which would be released by interaction with a compartment-specific receptor.
The basic scenario of Arf (ADP-ribosylation factor) activation by isolated Sec7 domains: how Sec7 domains couple membrane-recruitment to GDP/GTP exchange?
Small GTP-binding proteins of the Arf family are major regulators of membrane traffic in eukaryotic cells [1] . They are activated by exchange of GDP for GTP, a reaction that is catalysed by a family of GEFs (guanine nucleotide-exchange factors) carrying a catalytic domain called the Sec7 domain [2, 3] . Structural and biochemical data accumulated during the last decade have led to a comprehensive description of the basic events of the mechanism of nucleotide exchange. The Arf protein family is unique among small GTP-binding proteins in that their GDP/GTP cycle is associated with a cytoplasm/membrane cycle, which, unlike that of proteins of the Rab or Rho families, does not depend on accessory GDI (GDP dissociation inhibitor) regulators. Arf recruitment to membranes uses instead a built-in structural device, the interKey words: Arf protein, Brefeldin A, E/K mutation, GDP/GTP exchange, guanine nucleotideexchange factor (GEF), Sec 7 domain.
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Nomenclature: The interswitch is the β-hairpin that connects the switch 1 and switch 2 regions, which are conserved regions that allow small GTP-binding proteins to function as molecular switches by changing their conformation in response to the nature of the bound nucleotide.
switch (see the Nomenclature footnote; also see Figure 1 ), through which conformational changes at the nucleotidebinding site are propagated to the membrane-binding region at the opposite side of the protein [4] . The interswitch acts as a nucleotide-sensitive switch, as it undergoes a spectacular β-strand register shift on going from the GDP-bound to the GTP-bound form. It is locked in a retracted conformation in Arf-GDP by a myristoylated N-terminal helical extension, which biochemical and structural studies identified as a clasp for the conversion of Arf into its active conformation [5, 6] . The helix is unlocked by its interaction with a membrane, allowing the interswitch to toggle, which in turn destroys the N-terminal helix groove such that Arf-GTP is secured to membranes. In the absence of a GEF, myristoylated Arf-GDP partitions between a soluble form in which the N-terminal helix is locked, and a form weakly bound to membranes in which the N-terminal helix exposes to, and inserts its myristate into the membrane [5] .
Biochemical and structural studies have uncovered how these unique properties of Arf proteins are monitored by Sec7 domains. Biochemical studies first showed that the catalytic activity of Sec7 domains in stimulating GDP dissociation is dependent on the ability of Arf proteins to be recruited to a membrane. Sec7 domains are inactive on myristoylated full-length Arf in the absence of a membrane [7] , while the exchange activity can be reconstituted in solution by deleting the Arf N-terminal helix, thus mimicking the effect Step A, the initial step of the exchange reaction is trapped by BFA [11] . BFA is buried at the interface between Arf-GDP and the Sec7 domain and locks the interswitch in a retracted conformation that results in a low affinity for membranes. BFA-inhibited complexes for the full-length (step A, left) and truncated forms of Arf1 (step A , right) illustrate the cytosol/membrane distribution of the complex using isolated Sec7 domains. The inset shows the puckering of the interswitch in truncated Arf1 (green) compared with full-length Arf1 (yellow-green), resulting in a potential conflict for the closure of the N-terminal helix (in purple).
Step B, the charge reversal mutation traps a membrane-associated Arf-GDP-Sec7 intermediate after the interswitch toggle, but before the dissociation of GDP [11] .
Step C, formation of the nucleotide-free Arf-Sec7 intermediate occurs on membranes, as it requires that the interswitch adopts the toggled conformation [6] .
of membranes acting as cofactors of the exchange reaction [7, 8] . Structures of a series of intermediates of the exchange reaction have recently uncovered the structural dynamics of this coupling. As for all small GTP-binding proteins, GDP/GTP exchange catalysed by Sec7 domains is a multistep reaction. It initiates with a low affinity Arf-GDP-GEF complex, which proceeds to form a high affinity nucleotide-free intermediate to which GTP eventually binds to yield the active Arf-GTP form. Crystal structures have been obtained initially for a nucleotide-free Arf-Sec7 complex [6] and, recently, for two GDP-bound intermediates taking advantage of the inhibition of the reaction by either the fungal macrolide BFA (Brefeldin A) [9] [10] [11] [12] or by a charge reversal mutation of the invariant catalytic glutamate of the Sec7 domain [11, 13] . Remarkably, this series of structures can be ordered to provide snapshots of a three dimensional movie of the exchange reaction (Figure 1, steps A to C) . The initial intermediate is mimicked by the BFA-inhibited complex (Figure 1, step A) . It reveals that Arf-GDP docks on to the Sec7 domain before the interswitch toggle has taken place, and that the N-terminal extension fits readily on the Arf core in this complex, which altogether suggests that binding of Arf-GDP to the Sec7 domain could in principle occur in cytosol/ solution. The next stage of the reaction is trapped by the [E/K] mutation (Figure 1, step B) . The interswitch toggle has taken place in this complex and results in positioning the GDP nucleotide for electrostatic attack by the GEF, indicating that it takes place before dissociation of GDP [11] . Thus Arf-GDP has undergone a GTP-like conformational change that secures it to membranes before nucleotide dissociation can proceed, and the subsequent nucleotide-free intermediate can only form on a membrane [6] (Figure 1, step C) . Altogether, these structures show that the Sec7 domain is an active participant in coupling membrane recruitment to nucleotide exchange on Arf, and that these two events occur in sequence, such that nucleotide exchange is made structurally possible only on the fraction of Arf-GDP-Sec7 complexes that are transiently present at a membrane.
Dissection of a minimal biochemical and structural mechanism for BFA action on isolated Sec7 domains
BFA, which was used here as a tool to visualize snapshots of the exchange reaction, is a selective inhibitor of Arf activation in vivo [14, 15] . As discussed above, it acts by trapping an abortive Arf-GDP-GEF [9, 10] through binding at the interface between Arf-GDP and the Sec7 domain such that the resulting complex cannot proceed to nucleotide dissociation [8, 11, 12] . Structures of BFA-inhibited complexes obtained with either full-length Arf [11] or its truncated Arf1 17 form [11, 12] show that BFA binds to the Arf-GDPSec7 complex regardless of the conformational state of the N-terminal helix, which is closed and similar to soluble Arf-GDP in full-length Arf, while its absence in Arf1 17 mimicks membrane-associated Arf-GDP. Thus BFA is expected to bind well to both cytosolic Arf-GDP-Sec7 complex and its transiently membrane-bound form. Interestingly, a small puckering of the interswitch tip is observed in BFA-trapped Arf1 17-GDP-Sec7 complexes [11, 12] , but not in other Arf1 17-GDP structures [16] (Figure 1, step A, A and inset) . This small conformational difference can potentially hinder closing of the N-terminal helix in the transiently membraneassociated Arf-GDP-BFA-Sec7 complex and favour the displacement of the complex to membranes. Altogether, structural studies predict that BFA would have at the most a modest effect on the cytosol/membrane partition of Arf-GDP, but would result in the recruitment of Sec7 domains to membranes such that its membrane partition follows that of Arf-GDP. Biochemical studies using isolated Sec7 domains, myristoylated Arf1 and liposomes established that the Arf-GDP-BFA-Sec7 complex indeed forms in solution. BFA increases the recruitment of Arf-GDP only by a small amount [17] , this modest synergy probably resulting from the small puckering of the interswitch tip discussed above. In contrast, the essentially soluble Sec7 domain is dramatically recruited to the membrane by BFA in the presence of Arf1 [17] . Altogether, biochemical and structural data using isolated Sec7 domains provide a consistent scenario for the action of BFA: the only target of BFA is the Arf-GDP/Sec7 interface, the drug has little impact on the Arf-GDP ability to exchange from cytosol to membranes, and the Sec7 domain, as it is trapped in complex with Arf-GDP, is forced to follow its cytosol/membrane distribution.
The cellular effects of BFA on large ArfGEFs: the paradox of the specific distribution
The best characterized examples of BFA-sensitive ArfGEFs are found in the family of large ArfGEFs that comprise BIG1/2 and GBF1 in animal cells. As predicted from its effect on isolated Sec7 domains, BFA induces a dramatic increase in the membrane-bound fraction of these ArfGEFs (B.P. Zhao and P. Melançon, unpublished work; [18] ), which, however, is not accompanied by a concomitant increase of membranebound Arf [19, 20] . Mammalian GBF1 is largely cytosolic in the absence of BFA (B.P. Zhao and P. Melançon, unpublished work; [18, 21, 22] ). Live cell imaging with GFP-GBF1 showed that BFA treatment causes a sharp reduction in the rate of dissociation of the GEF from membranes, which leads to an up to 6-fold increase in GFP-GBF1 fluorescence at the Golgi complex, and eventual redistribution to the endoplasmic reticulum (B.P. Zhao and P. Melançon, unpublished work; [18] ). Likewise, BIG1 was found to be mostly cytosolic [23] and to be recruited to the juxtanuclear Golgi region upon BFA treatment [23, 24] . A similar increase in the membrane fraction upon BFA treatment was observed in plants for the BFA-sensitive GBF1-related GNOM [25] .
Although the reported recruitment of BFA-sensitive ArfGEFs to membranes is predicted from the basic effect of BFA on isolated Sec7 domains, this mechanism also predicts that the resulting ArfGEF compartmental re-distribution should follow that of Arf1 and be similar for all ArfGEFs acting on Arf1. It thus came as a paradox that the BFA-induced membrane recruitment of large mammalian ArfGEFs is specific, as shown by the fact that GBF1 and BIG1 become trapped on early and late membranes of the secretory pathway respectively where they show no overlap [24] . Thus these ArfGEFs must bear determinants that direct their specific targeting, and the fact that this targeting is enhanced by BFA, which acts at the catalytic Sec7 domain, indicates that the function of these determinants is somehow coupled to the process of Arf activation.
Conclusion and perspectives
An attractive hypothesis to account for the cellular effects of BFA would be that activation of Arf is coupled to the recruitment of ArfGEFs to the appropriate compartment, which would be best explained by intramolecular interactions that auto-inhibit the catalytic Sec7 domain of the cytosolic ArfGEF. Following release of this interaction by recruitment to a compartment-specific receptor, the Sec7 domain would then become exposed and available for Arf binding. It would be at that stage that BFA binds and freezes the complex at its target membrane. Compartment-specific interactions may be too weak to stabilize the ArfGEF on the target membrane, but would co-operate with the binding of Arf-GDP in the presence of BFA to yield a stable abortive complex. The conserved domain architecture of the BIG and GBF1 ArfGEFs argues in favour of a conserved mechanistic basis for such an auto-inhibition mechanism in these families [26] . Future investigations of the functions and interactions of the non-catalytic domains of ArfGEFs should shed light on these issues.
